191 related articles for article (PubMed ID: 30130283)
1. Intracrinology and menopause: the science describing the cell-specific intracellular formation of estrogens and androgens from DHEA and their strictly local action and inactivation in peripheral tissues.
Labrie F
Menopause; 2019 Feb; 26(2):220-224. PubMed ID: 30130283
[TBL] [Abstract][Full Text] [Related]
2. All sex steroids are made intracellularly in peripheral tissues by the mechanisms of intracrinology after menopause.
Labrie F
J Steroid Biochem Mol Biol; 2015 Jan; 145():133-8. PubMed ID: 24923731
[TBL] [Abstract][Full Text] [Related]
3. Science of intracrinology in postmenopausal women.
Labrie F; Bélanger A; Pelletier G; Martel C; Archer DF; Utian WH
Menopause; 2017 Jun; 24(6):702-712. PubMed ID: 28098598
[TBL] [Abstract][Full Text] [Related]
4. DHEA and intracrinology at menopause, a positive choice for evolution of the human species.
Labrie F; Labrie C
Climacteric; 2013 Apr; 16(2):205-13. PubMed ID: 23126249
[TBL] [Abstract][Full Text] [Related]
5. Androgens in women are essentially made from DHEA in each peripheral tissue according to intracrinology.
Labrie F; Martel C; Bélanger A; Pelletier G
J Steroid Biochem Mol Biol; 2017 Apr; 168():9-18. PubMed ID: 28153489
[TBL] [Abstract][Full Text] [Related]
6. DHEA, important source of sex steroids in men and even more in women.
Labrie F
Prog Brain Res; 2010; 182():97-148. PubMed ID: 20541662
[TBL] [Abstract][Full Text] [Related]
7. DHEA and its transformation into androgens and estrogens in peripheral target tissues: intracrinology.
Labrie F; Luu-The V; Labrie C; Simard J
Front Neuroendocrinol; 2001 Jul; 22(3):185-212. PubMed ID: 11456468
[TBL] [Abstract][Full Text] [Related]
8. Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone.
Labrie F; Luu-The V; Labrie C; Bélanger A; Simard J; Lin SX; Pelletier G
Endocr Rev; 2003 Apr; 24(2):152-82. PubMed ID: 12700178
[TBL] [Abstract][Full Text] [Related]
9. Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology.
Labrie F; Bélanger A; Cusan L; Candas B
J Clin Endocrinol Metab; 1997 Aug; 82(8):2403-9. PubMed ID: 9253308
[TBL] [Abstract][Full Text] [Related]
10. Intravaginal prasterone (DHEA) provides local action without clinically significant changes in serum concentrations of estrogens or androgens.
Labrie F; Martel C; Bérubé R; Côté I; Labrie C; Cusan L; Gomez JL
J Steroid Biochem Mol Biol; 2013 Nov; 138():359-67. PubMed ID: 23954500
[TBL] [Abstract][Full Text] [Related]
11. A low dose (6.5 mg) of intravaginal DHEA permits a strictly local action while maintaining all serum estrogens or androgens as well as their metabolites within normal values.
Labrie F; Martel C
Horm Mol Biol Clin Investig; 2017 Feb; 29(2):39-60. PubMed ID: 27997350
[TBL] [Abstract][Full Text] [Related]
12. DHEA and the intracrine formation of androgens and estrogens in peripheral target tissues: its role during aging.
Labrie F; Bélanger A; Luu-The V; Labrie C; Simard J; Cusan L; Gomez JL; Candas B
Steroids; 1998; 63(5-6):322-8. PubMed ID: 9618795
[TBL] [Abstract][Full Text] [Related]
13. Serum steroid concentrations remain within normal postmenopausal values in women receiving daily 6.5mg intravaginal prasterone for 12 weeks.
Martel C; Labrie F; Archer DF; Ke Y; Gonthier R; Simard JN; Lavoie L; Vaillancourt M; Montesino M; Balser J; Moyneur É;
J Steroid Biochem Mol Biol; 2016 May; 159():142-53. PubMed ID: 26972555
[TBL] [Abstract][Full Text] [Related]
14. Wide distribution of the serum dehydroepiandrosterone and sex steroid levels in postmenopausal women: role of the ovary?
Labrie F; Martel C; Balser J
Menopause; 2011 Jan; 18(1):30-43. PubMed ID: 20683211
[TBL] [Abstract][Full Text] [Related]
15. Is dehydroepiandrosterone a hormone?
Labrie F; Luu-The V; Bélanger A; Lin SX; Simard J; Pelletier G; Labrie C
J Endocrinol; 2005 Nov; 187(2):169-96. PubMed ID: 16293766
[TBL] [Abstract][Full Text] [Related]
16. Effect of exogenous estrogen on serum pregnenolone, cortisol, and androgens in postmenopausal women.
Abraham GE; Maroulis GB
Obstet Gynecol; 1975 Mar; 45(3):271-4. PubMed ID: 163457
[TBL] [Abstract][Full Text] [Related]
17. Steroid sex hormones and prolactin in postmenopausal women with generalized mammary carcinoma during prolonged dexamethasone treatment.
Borkowski A; L'hermite M; Dor P; Longeval E; Rozencweig M; Muquardt C; Van Cauter E
J Endocrinol; 1977 May; 73(2):235-46. PubMed ID: 140915
[TBL] [Abstract][Full Text] [Related]
18. An overview of dehydroepiandrosterone (EM-760) as a treatment option for genitourinary syndrome of menopause.
Holton M; Thorne C; Goldstein AT
Expert Opin Pharmacother; 2020 Mar; 21(4):409-415. PubMed ID: 31928093
[No Abstract] [Full Text] [Related]
19. Is vulvovaginal atrophy due to a lack of both estrogens and androgens?
Labrie F; Martel C; Pelletier G
Menopause; 2017 Apr; 24(4):452-461. PubMed ID: 27875388
[TBL] [Abstract][Full Text] [Related]
20. Lack of effect of intravaginal dehydroepiandrosterone (DHEA, prasterone) on the endometrium in postmenopausal women.
Portman DJ; Labrie F; Archer DF; Bouchard C; Cusan L; Girard G; Ayotte N; Koltun W; Blouin F; Young D; Wade A; Martel C; Dubé R;
Menopause; 2015 Dec; 22(12):1289-95. PubMed ID: 25968836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]